Hinge Health, Inc. HNGE
114.56 USD -1.42 (-1.22%)
Nov 6, 2026, 12:53 PM EST
111.00 Day range 118.70
30.08 52-week range 124.94
- YTD
- +146.64%
- 1 year
- +160.14%
News
benzinga.com Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135 Freedom Capital Markets analyst Gene Mannheimer maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $103 to $135.
benzinga.com Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131 Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $117 to $131.
benzinga.com Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145 Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $112 to $145.
benzinga.com Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132 Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $103 to $132.- benzinga.com RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135 RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $110 to $135.
- benzinga.com Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150 Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $125 to $150.
benzinga.com These Analysts Increase Their Forecasts On Hinge Health After Better-Than-Expected Q3 Results Hinge Health beat Q3 estimates, raised FY2026 sales guidance to $879M-$881M, and analysts lifted price targets; shares rose 1.3%.
benzinga.com Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $134 Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $105 to $134.- benzinga.com Stifel Maintains Buy on Hinge Health, Raises Price Target to $135 Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $130 to $135.
benzinga.com Needham Maintains Buy on Hinge Health, Raises Price Target to $135 Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $115 to $135.
seekingalpha.com Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript
marketbeat.com What Hinge Health (HNGE) Said on Its Q3 Earnings Call Hinge Health NYSE: HNGE reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement,…
zacks.com Hinge Health Inc. (HNGE) Beats Q3 Earnings and Revenue Estimates Hinge Health Inc. (HNGE) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.34 per share a year ago.
benzinga.com Hinge Health Q3 2026 Earnings Call Transcript Hinge Health (NYSE:HNGE) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com Hinge Health Raises FY2026 Sales Guidance from $856.000M-$860.000M to $879.000M-$881.000M vs $861.558M Est Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $856.000 million-$860.000 million to $879.000 million-$881.000 million vs $861.558 million estimate.
benzinga.com Hinge Health Q3 Adj. EPS $0.66 Beats $0.60 Estimate, Sales $235.000M Beat $224.561M Estimate Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.60 by 10 percent. This is a 3400 percent increase over losses of $(0.02) per…
businesswire.com Hinge Health reports record third quarter 2026 financial results SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong…
benzinga.com Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $140 Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $125 to $140.- benzinga.com Barclays Maintains Overweight on Hinge Health, Raises Price Target to $110 Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $100 to $110.
- benzinga.com 'Hinge Health Sees Hardware Deals Ahead in Digital Health Push'- Bloomberg https://www.bloomberg.com/news/articles/2026-10-07/hinge-health-sees-hardware-deals-ahead-in-digital-health-push
benzinga.com Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.- benzinga.com Needham Maintains Buy on Hinge Health, Raises Price Target to $115 Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $97 to $115.
- benzinga.com Baird Maintains Neutral on Hinge Health, Raises Price Target to $90 Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $85 to $90.
benzinga.com Jim Cramer: Buy This Energy Stock, It Is ‘Terrific’ Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.
benzinga.com Stifel Maintains Buy on Hinge Health, Raises Price Target to $115 Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $96 to $115.
benzinga.com Oura Reportedly Eyes $3 Billion IPO at More Than $16 Billion Valuation Oura Health is preparing for a potential U.S. IPO that could raise up to $3 billion and value the smart ring maker at more than $16 billion.
benzinga.com Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had’ Mad Money Lightning Round analysis: Hinge Health a buy after strong quarter, Stellantis not investible, Tractor Supply time to buy, and Cheniere Energy mixed results.- benzinga.com Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112 Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.
- benzinga.com RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $110 RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $75 to $110.
benzinga.com Citizens Maintains Market Outperform on Hinge Health, Raises Price Target to $107 Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target from $96 to $107.- benzinga.com Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $103 Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $90 to $103.
- benzinga.com Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $105 Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $100 to $105.
- benzinga.com Barclays Maintains Overweight on Hinge Health, Raises Price Target to $100 Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $97 to $100.
benzinga.com Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.- benzinga.com Needham Maintains Buy on Hinge Health, Raises Price Target to $97 Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $97.
- benzinga.com Hinge Health Raises FY2026 Sales Guidance from $818.000M-$824.000M to $856.000M-$860.000M vs $822.049M Est Hinge Health (NYSE:HNGE) raises FY2026 sales outlook from $818.000 million-$824.000 million to $856.000 million-$860.000 million vs $822.049 million estimate.
- benzinga.com Hinge Health Q2 Adj. EPS $0.59, Inline, Sales $212.817M Beat $201.030M Estimate Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.59 per share which met the analyst consensus estimate. This is a 13.24 percent decrease over earnings of $0.68 per share from the same…
- benzinga.com Citizens Maintains Market Outperform on Hinge Health, Raises Price Target to $96 Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target from $80 to $96.
- benzinga.com Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $100 Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $100.
- benzinga.com Barclays Maintains Overweight on Hinge Health, Raises Price Target to $97 Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $70 to $97.
- benzinga.com Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $125 Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $90 to $125.
- benzinga.com Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $108 Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $72 to $108.
- benzinga.com Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $90 Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $80 to $90.
- benzinga.com Baird Maintains Neutral on Hinge Health, Raises Price Target to $65 Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $55 to $65.
- benzinga.com Raymond James Maintains Outperform on Hinge Health, Raises Price Target to $80 Raymond James analyst Brian Peterson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $70 to $80.
- benzinga.com Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $76 Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $65 to $76.
- benzinga.com Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $90 Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $75 to $90.
- benzinga.com RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $75 RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $65 to $75.
- benzinga.com Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $85 Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $79 to $85.
- benzinga.com Barclays Maintains Overweight on Hinge Health, Raises Price Target to $70 Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $62 to $70.